Updated Approaches for Treating Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Written for primary care, hepatology, and gastroenterology teams
Addresses the need to improve awareness of new nomenclature, improved patient-centered communication, and strategies for coordination across multidisciplinary teams through clinician education
Includes discussion of recent FDA approvals, clinical trial results, and updated guidelines issued by the American Association for the Study of Liver Diseases (AASLD)